DPiLS: Exploring the Intervals in Distributed Laparoscopic Skills Training

Sponsor
Copenhagen Academy for Medical Education and Simulation (Other)
Overall Status
Completed
CT.gov ID
NCT05834504
Collaborator
(none)
39
1
2
6.9
5.7

Study Details

Study Description

Brief Summary

The objective of this trial is to investigate if short intervals (1-2 days) between training sessions are more efficient than practicing with longer intervals (6-8 days) between sessions during proficiency-based laparoscopic simulator training. Our hypothesis is that just 1-2 days of break between sessions is optimal for the acquisition of laparoscopic skills and that a shorter interval between sessions is optimal for training.

Condition or Disease Intervention/Treatment Phase
  • Other: Short distributed training (1-2 days)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Exploring the Intervals in Distributed Laparoscopic Skills Training
Actual Study Start Date :
Aug 29, 2022
Actual Primary Completion Date :
Mar 26, 2023
Actual Study Completion Date :
Mar 26, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

The control group will practice four basic skills and one procedural module on the Laparoscopic "Lapsim" Virtual Reality Simulator. They will practice with 6-8 days of break in between training sessions until proficiency level is achieved.

Experimental: Intervention Group

The intervention group will practice four basic skills and one procedural module on the Laparoscopic "Lapsim" Virtual Reality Simulator. They will practice with 1-2 days of break in between training sessions until proficiency level is achieved.

Other: Short distributed training (1-2 days)
The intervention group will practice four basic skills and one procedural module on the Laparoscopic "Lapsim" Virtual Reality Simulator. They will practice with 1-2 days of break in between training sessions until proficiency level is achieved.

Outcome Measures

Primary Outcome Measures

  1. Time to proficiency [6 months]

    The total effective training time (minutes) to reach the predefined proficiency level for both the four basic skills and the salpingectomy module.

Secondary Outcome Measures

  1. Retention test [6 months]

    The total effective training time (minutes) to reach the predefined proficiency level for both the four basic skills and the salpingectomy module after 3-5 weeks without laparoscopic training from the last training session.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Master's degree medical students, enrolled at a Danish University.
Exclusion Criteria:
  • Medical students that have participated in prior studies or similar involving laparoscopic training.

  • Performing laparoscopy surgery between the intervention and the retention test 3-5 weeks after.

  • No informed consent.

  • Does not speak Danish on a conversational level.

  • Any disability or injury regarding eyesight and mobility.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Copenhagen Academy For Medical Education and Simulation (Cames) Copenhagen Capital Region Denmark 2100

Sponsors and Collaborators

  • Copenhagen Academy for Medical Education and Simulation

Investigators

  • Study Director: Flemming Bjerrum, MD, Copenhagen Academy for Medical Education and Simulation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hai-Yen Tang, Principal Investigator, Copenhagen Academy for Medical Education and Simulation
ClinicalTrials.gov Identifier:
NCT05834504
Other Study ID Numbers:
  • DPiLS trial
First Posted:
Apr 28, 2023
Last Update Posted:
Apr 28, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 28, 2023